Skin Structures and Soft Tissue Infections
7 clinical trials · Condition
◉ Watch Skin Structures and Soft Tissue Infections
| Record | Firm | Date |
|---|---|---|
| Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI (NCT02877927) | Paratek Pharmaceuticals Inc | 2016-08-01 |
| The PLUS Study: Comparison of VicrylPlus® Versus Vicryl® for Repair of Perineal Tears (NCT02863874) | Region Skane | 2016-01-01 |
| Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2 (NCT02607618) | Motif Bio | 2015-11-01 |
| Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1 (NCT02600611) | Motif Bio | 2015-11-01 |
| Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23) (NCT02378480) | Paratek Pharmaceuticals Inc | 2015-06-01 |
| Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections (NCT01984684) | Melinta Therapeutics, Inc. | 2014-05-01 |
Track Skin Structures and Soft Tissue Infections automatically
Every clearance here is in the API, with alerts when new ones post.